Market Overview
Mordor Intelligence data shows the precision medicine market held a global value of USD?85.24?billion in 2025. By 2030, the market is expected to reach USD?109.83?billion, with a steady CAGR of 5.2% . This growth stems from advancing genomics, rising use of companion diagnostics, and deeper insights into genetic disorders. Despite hurdles like high cost and complex reimbursements, sectors such as cell and gene therapies are poised to expand treatment options and fuel demand,

Technological & Healthcare Catalysts
Precision medicine thrives on technologies such as gene sequencing, bioinformatics, and big data analytics. These tools are essential for developing personalized treatments, especially in oncology, immunology, and rare diseases. Mordor flagged companion diagnostics and genetic testing as key market factors—despite pricing and reimbursement shifts, this segment is offering new avenues for tailored therapies.

Regional Outlook
North America: Leading the global market with USD?28.32?billion in 2025, expanding to USD?45.71?billion by 2030 at 10.05% CAGR. This surge is backed by strong chronic disease rates, genome tech advances, and sizable government funding.

Europe: Forecasted to grow from USD?27.30?billion in 2025 to USD?45.73?billion by 2030 (CAGR?10.86%). Growth drivers include collaborative gene research projects and national precision medicine strategies.

China: Set to increase from USD?6.99?billion in 2025 to USD?12.70?billion by 2030, at a CAGR of 12.7%, fueled by expanding genomics, targeted therapies, and improved drug coverage.

Applications & Key Technologies
Oncology remains the primary application area, supported by companion diagnostics and genomic profiling to deliver tailored cancer treatment .
Gene sequencing is a central technology segment, particularly in North America, where it drives diagnostics and targeted care.

Competitive Landscape
Key players in the precision medicine market (globally) include Pfizer,

Qiagen,

Thermo Fisher Scientific,

Novartis, and Medtronic

In Europe, leading companies include AstraZeneca, Danaher, Qiagen, Thermo Fisher, and Abbott.

In China, major market participants are Hoffmann-La Roche, Zhongyuan Union Stem Cell, Amoy Diagnostics, New Horizon Health, and Berry Genomics.

Opportunities & Challenges
Opportunities:
Genomic and AI-led innovation: Continued adoption of gene sequencing, bioinformatics, and AI-driven analytics is enabling novel therapeutics and diagnostics.

Government and private sector support: Public funding and private investments are accelerating R&D, especially in precision oncology and personalized treatments.

Challenges:
Cost and coverage issues: The high cost of tests and therapies, complicated reimbursement frameworks, and data privacy concerns could slow adoption.

Data-sharing regulations: Particularly critical in genomics-heavy regions like China and Europe, where cross-border data movement may be restricted.

Future Outlook
Mordor Intelligence forecasts steady growth for the precision medicine market through 2030, with global revenues expected to surpass USD?100?billion. Key growth drivers include expanding genomics technologies, AI-powered tools, and policy initiatives. The fastest growth is expected in North America, Europe, and China, underpinned by collaboration, funding, and healthcare reform.



This outlook places precision medicine as a core pillar in modern healthcare—enabling better disease targeting, enhanced drug development, and improved patient outcomes.

Conclusion

The precision medicine market is steadily evolving as healthcare systems worldwide move toward more tailored approaches to treatment. Driven by advancements in genomics, companion diagnostics, and the growing demand for personalized care—especially in oncology—the industry is gaining traction across regions. North America continues to lead due to its robust research ecosystem and funding support, while Europe and Asia-Pacific are showing strong growth potential through strategic collaborations and healthcare reforms.

Read More: https://www.mordorintelligence.com/industry-reports/precision-medicine-market

About Mordor Intelligence:

Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.

With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.

For any inquiries or to access the full report, please contact:

[email protected]
https://www.mordorintelligence.com/